舒利迭荟萃分析遗漏了重要特征，并夸大了其相对于同期长效β2受体激动剂/吸入性糖皮质激素装置的任何优势。 - Suppr

Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devices.

Metcalfe Scott, Moodie Peter

J Allergy Clin Immunol. 2004 Mar;113(3):568-9; author reply 569-71. doi: 10.1016/j.jaci.2003.12.005.

Abstract

摘要

J Allergy Clin Immunol. 2004 Mar;113(3):568-9; author reply 569-71. doi: 10.1016/j.jaci.2003.12.005.

Clin Ther. 2009 Dec;31(12):2779-803. doi: 10.1016/j.clinthera.2009.12.021.

J Allergy Clin Immunol. 2001 Apr;107(4):746. doi: 10.1067/mai.2001.114049.

Br J Clin Pharmacol. 2003 Nov;56(5):494-500. doi: 10.1046/j.1365-2125.2003.01887.x.

JAMA. 2009 Jan 28;301(4):365-6. doi: 10.1001/jama.2008.991.

Lancet. 2010 Sep 4;376(9743):750-1. doi: 10.1016/S0140-6736(10)61158-0.

J Asthma. 2005 Nov;42(9):715-24. doi: 10.1080/02770900500305748.

N Engl J Med. 2007 Aug 2;357(5):504-5; author reply 505-6.

Drugs. 2005;65(12):1715-34. doi: 10.2165/00003495-200565120-00012.

Chest. 2000 Feb;117(2):611-3. doi: 10.1378/chest.117.2.611.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):107-16.

Br J Pharmacol. 2007 Sep;152(1):83-90. doi: 10.1038/sj.bjp.0707381. Epub 2007 Jul 9.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。